Catheter Precision Inc (VTAK)
0.5489
-0.01
(-1.98%)
USD |
NYAM |
Apr 30, 16:00
0.5299
-0.02
(-3.46%)
After-Hours: 20:00
Catheter Precision SG&A Expense (Quarterly): 2.729M for Dec. 31, 2023
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 2.729M |
September 30, 2023 | 2.745M |
June 30, 2023 | 1.415M |
March 31, 2023 | 10.23M |
December 31, 2022 | 7.958M |
September 30, 2022 | 3.514M |
June 30, 2022 | 2.476M |
March 31, 2022 | 2.302M |
December 31, 2021 | 4.19M |
September 30, 2021 | 4.211M |
June 30, 2021 | 3.398M |
March 31, 2021 | 3.677M |
December 31, 2020 | 6.379M |
September 30, 2020 | 4.695M |
Date | Value |
---|---|
June 30, 2020 | 7.896M |
March 31, 2020 | 6.285M |
December 31, 2019 | 8.642M |
September 30, 2019 | 15.89M |
June 30, 2019 | 13.79M |
March 31, 2019 | 13.23M |
December 31, 2018 | 14.81M |
September 30, 2018 | 5.366M |
June 30, 2018 | 7.615M |
March 31, 2018 | 2.639M |
December 31, 2017 | 3.015M |
September 30, 2017 | 1.904M |
June 30, 2017 | 8.283M |
March 31, 2017 | 1.745M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
1.415M
Minimum
Jun 2023
15.89M
Maximum
Sep 2019
5.917M
Average
4.211M
Median
Sep 2021
SG&A Expense (Quarterly) Benchmarks
Perspective Therapeutics Inc | 1.694M |
Retractable Technologies Inc | 4.158M |
InfuSystems Holdings Inc | 13.26M |
Xtant Medical Holdings Inc | 20.45M |
Asensus Surgical Inc | 7.773M |